APA (7th ed.) Citation

Londoño, A. C., Londoño, A. C., & Mora, C. A. High efficacy therapy to prevent the formation of meningeal tertiary lymphoid organs after CXCL13 index screening in early multiple sclerosis. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Londoño, Ana C., Ana C. Londoño, and Carlos A. Mora. High Efficacy Therapy to Prevent the Formation of Meningeal Tertiary Lymphoid Organs After CXCL13 Index Screening in Early Multiple Sclerosis. Frontiers Media S.A.

MLA (9th ed.) Citation

Londoño, Ana C., et al. High Efficacy Therapy to Prevent the Formation of Meningeal Tertiary Lymphoid Organs After CXCL13 Index Screening in Early Multiple Sclerosis. Frontiers Media S.A.